High-Tech Gründerfonds
HTGF backs WhatsBroadcast in €5m series-A
Investors include Müller Medien, Media + More Ventures, Wessel Management and minority shareholders
HTGF, HIF in €800,000 round for Rodos Biotarget
Otto Gies previously invested in the company via crowdfunding platforms Seedmatch and Aescuvest
HTGF, IFH sell Custom Cells to P3 Group
Altana also made a financial exit but will continue to cooperate with Custom Cells operationally
HTGF backs €7m seed round for Zimmer Biotech
Zimmer Biotech will focus on developing a skin cancer drug based on 5-Aminolevulinic acid
HTGF sells stake in Evoxx to Advanced Enzyme
High-Tech Gründerfonds is selling its stake in the biotech firm after a 10-year holding period
HTGF and MBG back €720,000 seed round for Stimos
HTGF says the technology addresses a problem affecting patients and the health economy
HTGF in €3m series-B round for POS Pulse
Round was led by former Schleich managing director Paul Kraut along with moebel.de founder Robert Kabs
High-Tech Gründerfonds sells Fruux
GP sells its stake to the company's founding partner after a five-year holding period
HTGF, Media Ventures et al. in $8.5m round for Make.tv
Corporate venture players Voyager Capital, Microsoft Ventures and Vulcan Capital also back the round
VCs exit Propertybase to Boston Logic
Neuhaus Partners, HTGF, Bayern Kapital and BayBG all report a successful exit from the investment
HTGF holds first close for third fund on €245m
Fund has a target of €300m and will begin making early-stage investments in Q4 2017
Helvetia Venture Fund leads funding round for Baimos
HCS Beteiligungsgesellschaft, Berendsen Holding, High-Tech Gründerfonds and Bayern Kapital also invest
Principia leads €6.5m series-B for neurology firm Wise
Existing investors Atlante Ventures, High-Tech Gründerfonds, F3F and Antares join the round
HTGF, Kima exit eWings.com in trade sale
Hogg Robinson Group enters into an agreement to acquire the digital business-travel service
One Peak, Morgan Stanley invest €22m in Ecointense
Transaction constitutes an exit for BBAF and Wecken & Cie, while HTGF retains a significant stake
42Cap, HTGF and Littlerock in €1.8m round for MoBerries
Company will use the new funding to develop its technology and expand operations internationally
LSP leads €15m series-A for Cardior Pharmaceuticals
New funding will allow the company to develop its lead compound, which targets RNAs linked to heart failure
HTGF et al. invest in Numaferm
European Investment Fund and angel investors also participated in the seed funding round
Target and HTGF in $2.6m Simplaex series-A
Deal is the first of the year for Target and the 15th for High-Tech Gründerfonds
HTGF in €1.5m seed round for Replex
Fresh capital will be used to expand into the US market, with a new office recently opened in San Francisco
HTGF sells Collinor to Godesys
Medium-term goal of the acquisition is to integrate Collinor's software into Godesys's project management systems
Shot in the arm for DACH healthcare market
Consolidation opportunities in the mid-market fuel increased investment from private equity, with aggregate volume reaching a six-year high
HTGF and IFH back KSK Diagnostics
New funding will be used to develop point-of-care tests by utilising isothermal amplification technology
HTGF et al. sell Symetis to Boston Scientific for $435m
Companies have developed complementary heart valve technologies